Cui Cui
Coverage of Cui Cui in the Nexus archive.
- Jefferies' Cui Cui on Wuxi Apptec's Earnings
Jefferies Head of Asia Healthcare Research Cui Cui stated the outlook for Wuxi Apptec remains bright. The company reported an earnings beat and raised its full year guidance, prompting analysis on 'Bloomberg: The China Show'.
- Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to an entity list linked to China’s military, but analysts say the move will not deter multinational drug makers from collaborating with Chinese firms due to cost advantages. Jefferies' healthcare research head Cui Cui noted that cost efficiency in China's pharmaceutical manufacturing remains a key factor for multinational companies.
- Chinese pharmaceutical firms’ cost advantages trump Pentagon blacklist: analysts
The Pentagon added Chinese pharmaceutical contractor WuXi AppTec to a list of entities it alleges are linked to the country’s military, but analysts say the blacklisting will not stop multinational drug makers from collaborating with China’s biopharmaceutical firms due to cost advantages.